T1	CHEM 19 37	hierro polimaltosa
#1	AnnotatorNotes T1	C0076040; iron polymaltose; Organic Chemical · Pharmacologic Substance
T2	CHEM 40 55	sulfato ferroso
#2	AnnotatorNotes T2	C0060282; ferrous sulfate; Pharmacologic Substance · Inorganic Chemical
T3	PROC 64 75	tratamiento
#3	AnnotatorNotes T3	C0087111; Therapeutic procedure; Therapeutic or Preventive Procedure
T4	DISO 82 100	anemia ferropénica
#4	AnnotatorNotes T4	C0162316; Iron deficiency anemia; Disease or Syndrome
T5	PROC 102 134	estudio prospectivo aleatorizado
#5	AnnotatorNotes T5	C0033522; Prospective Studies; Research Activity + C0206034; Clinical Trials, Randomized; Research Activity
T6	PROC 283 341	se comparó prospectivamente la eficacia y la tolerabilidad
#6	AnnotatorNotes T6	C0033522; Prospective Studies; Research Activity + C3274448; Tolerability Study; Research Activity + C1707887; Efficacy Study; Research Activity
T7	CHEM 219 250	hidróxido férrico polimaltosado
#7	AnnotatorNotes T7	C0076040; iron polymaltose; Organic Chemical · Pharmacologic Substance
T8	CHEM 266 281	sulfato ferroso
#8	AnnotatorNotes T8	C0060282; ferrous sulfate; Pharmacologic Substance · Inorganic Chemical
T9	PROC 741 749	ferremia
#9	AnnotatorNotes T9	C1318312; Serum iron measurement; Laboratory Procedure
T10	CHEM 483 495	transferrina
#10	AnnotatorNotes T10	C0040679; Transferrin; Amino Acid, Peptide, or Protein · Biologically Active Substance
T11	PROC 566 579	aleatorizados
#11	AnnotatorNotes T11	C0034656; Randomization; Research Activity
T12	PROC 530 544	estratificados
#12	AnnotatorNotes T12	C1514983; Stratification; Research Activity
T13	CHEM 593 624	hidróxido férrico polimaltosado
#13	AnnotatorNotes T13	C0076040; iron polymaltose; Organic Chemical · Pharmacologic Substance
T14	CHEM 627 642	sulfato ferroso
#14	AnnotatorNotes T14	C0060282; ferrous sulfate; Pharmacologic Substance · Inorganic Chemical
T15	PROC 701 712	hematócrito
#15	AnnotatorNotes T15	C0018935; Hematocrit procedure; Laboratory Procedure
T16	PROC 764 773	ferritina
#16	AnnotatorNotes T16	C0373607; Ferritin measurement; Laboratory Procedure
T17	PROC 778 801	tolerabilidad se evaluó
#17	AnnotatorNotes T17	C3274448; Tolerability Study; Research Activity
T18	CHEM 943 974	hidróxido férrico polimaltosado
#18	AnnotatorNotes T18	C0076040; iron polymaltose; Organic Chemical · Pharmacologic Substance
T19	CHEM 983 998	sulfato ferroso
#19	AnnotatorNotes T19	C0060282; ferrous sulfate; Pharmacologic Substance · Inorganic Chemical
T20	PROC 1015 1026	hematócrito
#20	AnnotatorNotes T20	C0018935; Hematocrit procedure; Laboratory Procedure
T21	PROC 1189 1197	Ferremia
#21	AnnotatorNotes T21	C1318312; Serum iron measurement; Laboratory Procedure
T22	CHEM 1089 1104	sulfato ferroso
#22	AnnotatorNotes T22	C0060282; ferrous sulfate; Pharmacologic Substance · Inorganic Chemical
T23	CHEM 1115 1146	hidróxido férrico polimaltosado
#23	AnnotatorNotes T23	C0076040; iron polymaltose; Organic Chemical · Pharmacologic Substance
T24	PROC 1212 1221	ferritina
#24	AnnotatorNotes T24	C0373607; Ferritin measurement; Laboratory Procedure
T25	CHEM 1278 1293	sulfato ferroso
#25	AnnotatorNotes T25	C0060282; ferrous sulfate; Pharmacologic Substance · Inorganic Chemical
T26	CHEM 1374 1389	sulfato ferroso
#26	AnnotatorNotes T26	C0060282; ferrous sulfate; Pharmacologic Substance · Inorganic Chemical
T27	CHEM 1459 1474	sulfato ferroso
#27	AnnotatorNotes T27	C0060282; ferrous sulfate; Pharmacologic Substance · Inorganic Chemical
T28	PROC 1558 1566	ferremia
#28	AnnotatorNotes T28	C1318312; Serum iron measurement; Laboratory Procedure
T29	PROC 1569 1579	saturación
#29	AnnotatorNotes T29	C1277709; Transferrin saturation measurement; Laboratory Procedure
T30	PROC 1518 1529	hematócrito
#30	AnnotatorNotes T30	C0018935; Hematocrit procedure; Laboratory Procedure
T31	CHEM 1618 1633	sulfato ferroso
#31	AnnotatorNotes T31	C0060282; ferrous sulfate; Pharmacologic Substance · Inorganic Chemical
T32	DISO 1639 1654	mala tolerancia
T33	CHEM 1672 1703	hidróxido férrico polimaltosado
#32	AnnotatorNotes T33	C0076040; iron polymaltose; Organic Chemical · Pharmacologic Substance
T34	PROC 1748 1769	suspender tratamiento
#33	AnnotatorNotes T34	C0850893; stop medication; Therapeutic or Preventive Procedure
T35	CHEM 1790 1805	sulfato ferroso
#34	AnnotatorNotes T35	C0060282; ferrous sulfate; Pharmacologic Substance · Inorganic Chemical
T36	CHEM 2050 2081	hidróxido férrico polimaltosado
#35	AnnotatorNotes T36	C0076040; iron polymaltose; Organic Chemical · Pharmacologic Substance
T37	PROC 410 421	hemoglobina
#36	AnnotatorNotes T37	C0518015; Hemoglobin measurement; Laboratory Procedure
T38	PROC 434 459	volumen corpuscular medio
#37	AnnotatorNotes T38	C0863148; Mean corpuscular volume analyses; Laboratory Procedure
T39	PROC 469 495	saturación de transferrina
#38	AnnotatorNotes T39	C1277709; Transferrin saturation measurement; Laboratory Procedure
T40	PROC 503 512	ferritina
#39	AnnotatorNotes T40	C0373607; Ferritin measurement; Laboratory Procedure
T41	PROC 688 699	hemoglobina
#40	AnnotatorNotes T41	C0518015; Hemoglobin measurement; Laboratory Procedure
T42	PROC 714 739	volumen corpuscular medio
#41	AnnotatorNotes T42	C0863148; Mean corpuscular volume analyses; Laboratory Procedure
T43	PROC 751 761	saturación
#42	AnnotatorNotes T43	C1277709; Transferrin saturation measurement; Laboratory Procedure
T44	PROC 1001 1012	Hemoglobina
#43	AnnotatorNotes T44	C0518015; Hemoglobin measurement; Laboratory Procedure
T45	PROC 1199 1209	saturación
#44	AnnotatorNotes T45	C1277709; Transferrin saturation measurement; Laboratory Procedure
T46	PROC 1505 1516	hemoglobina
#45	AnnotatorNotes T46	C0518015; Hemoglobin measurement; Laboratory Procedure
T47	PROC 1531 1556	volumen corpuscular medio
#46	AnnotatorNotes T47	C0863148; Mean corpuscular volume analyses; Laboratory Procedure
T48	PROC 1718 1729	hemoglobina
#47	AnnotatorNotes T48	C0518015; Hemoglobin measurement; Laboratory Procedure
T49	PROC 2031 2042	tratamiento
#48	AnnotatorNotes T49	C0087111; Therapeutic procedure; Therapeutic or Preventive Procedure
T50	LIVB 385 390	Niños
#49	AnnotatorNotes T50	C0008059; Child; Age Group
T51	Age 394 404	6-48 meses
T53	Dose 644 651	5 mg/kg
T54	Frequency 651 655	/día
T55	Duration 665 672	90 días
T56	LIVB 888 892	niño
#50	AnnotatorNotes T56	C0008059; Child; Age Group
T57	LIVB 925 934	pacientes
#51	AnnotatorNotes T57	C0030705; Patients; Patient or Disabled Group
T58	Date 1153 1162	el día 30
T59	Date 1225 1231	día 90
T61	LIVB 1439 1448	pacientes
#52	AnnotatorNotes T61	C0030705; Patients; Patient or Disabled Group
T62	LIVB 1599 1607	paciente
#53	AnnotatorNotes T62	C0030705; Patients; Patient or Disabled Group
T64	LIVB 1965 1974	pacientes
#54	AnnotatorNotes T64	C0030705; Patients; Patient or Disabled Group
T65	LIVB 353 362	Población
#55	AnnotatorNotes T65	C1257890; Population; Population Group
A1	Population_data T50 Age
A2	Population_data T56 Age
R1	Used_for Arg1:T2 Arg2:T3	
R2	Used_for Arg1:T1 Arg2:T3	
R3	Has_Age Arg1:T50 Arg2:T51	
T52	Result_or_Value 422 432	<11,0 g/dl
R4	Has_Result_or_Value Arg1:T37 Arg2:T52	
T60	Result_or_Value 460 466	<72 fl
R5	Has_Result_or_Value Arg1:T38 Arg2:T60	
T63	Result_or_Value 496 500	≤15%
R6	Has_Result_or_Value Arg1:T39 Arg2:T63	
T66	Result_or_Value 513 522	<16 ng/ml
R7	Has_Result_or_Value Arg1:T40 Arg2:T66	
R8	Experiences Arg1:T50 Arg2:T37	
R9	Experiences Arg1:T50 Arg2:T38	
R10	Experiences Arg1:T50 Arg2:T39	
R11	Experiences Arg1:T50 Arg2:T40	
R12	Before Arg1:T12 Arg2:T11	
R13	Before Arg1:T11 Arg2:T13	
R14	Before Arg1:T11 Arg2:T14	
R15	Experiences Arg1:T50 Arg2:T13	
R16	Experiences Arg1:T50 Arg2:T14	
R17	Has_Dose_or_Strength Arg1:T14 Arg2:T53	
R18	Has_Dose_or_Strength Arg1:T13 Arg2:T53	
R19	Has_Frequency Arg1:T14 Arg2:T54	
R20	Has_Frequency Arg1:T13 Arg2:T54	
R21	Has_Duration_or_Interval Arg1:T14 Arg2:T55	
R22	Has_Duration_or_Interval Arg1:T13 Arg2:T55	
T67	Quantifier_or_Qualifier 807 812	buena
#56	AnnotatorNotes T67	C0205170; Good; Qualitative Concept
T68	Quantifier_or_Qualifier 814 821	regular
#57	AnnotatorNotes T68	C0205272; Regular; Qualitative Concept
R23	Has_Quantifier_or_Qualifier Arg1:T17 Arg2:T67	
R24	Has_Quantifier_or_Qualifier Arg1:T17 Arg2:T68	
T69	Quantifier_or_Qualifier 824 828	mala
#58	AnnotatorNotes T69	C2700379; Poor - qualifier; Qualitative Concept | C0542537; Poor - grade value; Qualitative Concept
R25	Has_Quantifier_or_Qualifier Arg1:T17 Arg2:T69	
R26	Experiences Arg1:T56 Arg2:T17	
R27	Experiences Arg1:T57 Arg2:T18	
R28	Experiences Arg1:T57 Arg2:T19	
R33	Overlap Arg1:T44 Arg2:T58	
R34	Overlap Arg1:T20 Arg2:T58	
T70	CONC 1172 1177	final
#59	AnnotatorNotes T70	C2983670; Study End Date; Temporal Concept
R35	Overlap Arg1:T44 Arg2:T70	
R36	Overlap Arg1:T20 Arg2:T70	
R37	Overlap Arg1:T24 Arg2:T59	
R38	Overlap Arg1:T45 Arg2:T59	
R39	Overlap Arg1:T21 Arg2:T59	
R43	Experiences Arg1:T61 Arg2:T27	
T71	Observation 1483 1516	valores normales para hemoglobina
#60	AnnotatorNotes T71	C0459422; Normal result; Finding | C0586624; Normal laboratory finding; Finding (?)
R44	Experiences Arg1:T61 Arg2:T71	
R45	Experiences Arg1:T62 Arg2:T31	
R46	Experiences Arg1:T62 Arg2:T33	
R47	Causes Arg1:T31 Arg2:T32	
R48	Before Arg1:T32 Arg2:T34	
R49	Used_for Arg1:T33 Arg2:T34	
R50	Used_for Arg1:T31 Arg2:T34	
R51	Experiences Arg1:T62 Arg2:T34	
R52	Experiences Arg1:T62 Arg2:T48	
T72	Observation 1709 1729	caída de hemoglobina
#61	AnnotatorNotes T72	C1821769; Decreased hemoglobin (Hgb); Finding
R53	Experiences Arg1:T62 Arg2:T72	
R54	Causes Arg1:T33 Arg2:T72	
R55	Before Arg1:T72 Arg2:T34	
R56	Causes Arg1:T27 Arg2:T71	
T73	Observation 1483 1504;1531 1556	valores normales para volumen corpuscular medio
#62	AnnotatorNotes T73	C0860925; Mean corpuscular volume normal result; Finding
T74	Observation 1483 1504;1518 1529	valores normales para hematócrito
#63	AnnotatorNotes T74	C0740316; Hematocrit normal; Finding
T75	Observation 1483 1504;1558 1566	valores normales para ferremia
#64	AnnotatorNotes T75	C0853783; Blood iron normal; Finding
T76	Observation 1483 1504;1569 1579	valores normales para saturación
#65	AnnotatorNotes T76	C3551241; Normal transferrin saturation; Finding
R62	Causes Arg1:T27 Arg2:T74	
R63	Causes Arg1:T27 Arg2:T73	
R64	Causes Arg1:T27 Arg2:T75	
R65	Causes Arg1:T27 Arg2:T76	
T77	Result_or_Value 1919 1932	normalización
#66	AnnotatorNotes T77	C1873497; Normal assessment finding; Finding (?)
R66	Experiences Arg1:T64 Arg2:T35	
R67	Causes Arg1:T35 Arg2:T77	
T78	Observation 2019 2042	adhesión al tratamiento
#67	AnnotatorNotes T78	C2364172; Adherence To Medication Regime; Finding
R69	Experiences Arg1:T64 Arg2:T36	
R70	Used_for Arg1:T35 Arg2:T49	
R71	Overlap Arg1:T78 Arg2:T49	
R72	Experiences Arg1:T64 Arg2:T78	
R73	Used_for Arg1:T36 Arg2:T49	
#68	AnnotatorNotes T32	C0277585; Intolerance to drug; Pathologic Function
A3	Experiencer T65 Patient
A4	Experiencer T50 Patient
A5	Experiencer T56 Patient
A6	Experiencer T57 Patient
A7	Experiencer T61 Patient
A8	Experiencer T62 Patient
A9	Experiencer T64 Patient
R30	Has_Result_or_Value Arg1:T30 Arg2:T74	
R31	Has_Result_or_Value Arg1:T29 Arg2:T76	
R32	Has_Result_or_Value Arg1:T28 Arg2:T75	
R29	Has_Result_or_Value Arg1:T46 Arg2:T71	
R40	Has_Result_or_Value Arg1:T48 Arg2:T72	
